We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Review · June 30, 2020

Effective Management of Type 2 Diabetes and Cognitive Dysfunction

The Lancet Diabetes & Endocrinology


Additional Info

The Lancet Diabetes & Endocrinology
Type 2 Diabetes and Cognitive Dysfunction—Towards Effective Management of Both Comorbidities
Lancet Diabetes Endocrinol 2020 Jun 01;8(6)535-545, V Srikanth, AJ Sinclair, F Hill-Briggs, C Moran, GJ Biessels

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading